Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the

Cynthiane J Morgenweck1

  • 1Center for Bioethics and Medical Humanities, Institute for Health and Society, Medical College of Wisconsin, Wisconsin, USA. cmorg@mcw.edu

Insights

Physicians should discuss deactivating intracardiac devices, like defibrillators, with patients. Understanding ethical device removal and patient wishes is crucial for informed decision-making.

Area of Science:

  • Cardiology
  • Medical Ethics
  • Electrophysiology

Background:

  • Increasing use of intracardiac devices has led to greater awareness of patient burdens, particularly defibrillator shocks.
  • Patient requests for device deactivation and physician reluctance highlight a need for ethical guidance.

Purpose of the Study:

  • To update physicians on the ethical considerations surrounding the deactivation and removal of intracardiac devices.
  • To address the growing need for clarity on device deactivation protocols.

Main Methods:

  • Review of current literature and guidelines on intracardiac device deactivation.
  • Analysis of patient and physician perspectives on device deactivation.

Main Results:

  • The American Heart Rhythm Society has issued a consensus statement on the ethical removal of intracardiac devices.
  • Surveys reveal significant misunderstandings among patients and physicians regarding device deactivation.

Conclusions:

  • Physicians should proactively initiate conversations about deactivation, ideally during device implantation.
  • Sharing case studies can improve physician guidance for patients and families.
  • Institutions should establish clear guidelines for intracardiac device deactivation.
Abstract

Related Concept Videos

Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.